MedPath

Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

Phase 3
Terminated
Conditions
Schizophrenia
Interventions
Registration Number
NCT03121586
Lead Sponsor
ACADIA Pharmaceuticals Inc.
Brief Summary

To evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
996
Inclusion Criteria
  1. Patient is able to understand and provide signed informed consent

  2. Has a caregiver or some other identified responsible person (e.g., family member, social worker, caseworker, or nurse) considered reliable by the Investigator in providing support to the subject to help ensure compliance with study treatment, study visits, and protocol procedures and who is also able to provide input helpful for completing study rating scale

  3. Is completing the Week 6 visit in Study ACP-103-034 or the Week 26 visit in Study ACP-103-038 or 064 while continuing to take his/her assigned dose of blinded study drug and may, in the Investigator's opinion, benefit from continued adjunctive treatment with pimavanserin to a antipsychotic

  4. If the subject is female, she must not be pregnant or breastfeeding. She must also be of non-childbearing potential (defined as either surgically sterilized or at least 1 year postmenopausal) or must agree to use two clinically acceptable methods of contraception

  5. The main background antipsychotic with which the subject is being treated must continue to be on one of the antipsychotics listed below:

    • Aripiprazole

    • Aripiprazole long-acting injectables:

      • Abilify Maintena®
      • Aristada®
    • Asenapine

    • Risperidone

    • Risperidone long-acting injection

    • Olanzapine

    • Paliperidone extended release (ER) (≤9 mg)

    • Paliperidone palmitate

      • Invega Sustenna® (≤156 mg)
      • Invega Trinza® (≤546 mg)
      • Trevicta® (≤350 mg)
      • Xeplion® (≤100 mg)
    • Lurasidone

    • Cariprazine

    • Brexpiprazole

    • Asenapine

Read More
Exclusion Criteria
  1. Patient is judged by the Investigator or the Medical Monitor to be inappropriate for the study (e.g., significantly noncompliant in Studies ACP-103-034, -038, or -064)

  2. A urine drug screen (UDS) result at Baseline that indicates the presence of any tested prohibited substance of potential abuse

    1. Subjects from Studies 034 and 038 with a result indicating the presence of marijuana are permitted, if allowed by medical regulations, if they agree to abstain from marijuana use during the study and the medical monitor approves the subject's participation
    2. Subjects from Study 064 with a result indicating the presence of marijuana are not permitted in the study
  3. Is taking a medication or drug or other substance that is prohibited according to this protocol

  4. Known family or personal history or symptoms of long QT syndrome or risk factors for torsade de pointes and/or sudden death, including symptomatic bradycardia, hypokalemia or hypomagnesemia, and the presence of congenital prolongation of the QT interval

  5. Patient has current evidence of a serious and/or unstable psychiatric, neurologic, cardiovascular, respiratory, gastrointestinal, renal, hepatic, hematologic, or other medical disorder, including cancer or malignancies, which would affect the patient's ability to participate in the study.

Patients will be evaluated at screening to ensure that all criteria for study participation are met. Patients may be excluded from the study based on these assessments (and specifically if it is determined that their baseline health and psychiatric condition do not meet all pre-specified entry criteria).

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Drug - PimavanserinPimavanserinPimavanserin 34 mg, 20 mg, or 10 mg, + background antipsychotic, taken once daily by mouth
Primary Outcome Measures
NameTimeMethod
Evaluate the long-term safety and tolerability of pimavanserin (e.g., Summary of Treatment-Emergent Adverse Events [Safety and Tolerability])52 weeks

Evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (161)

141-Hassman Research Institute

🇺🇸

Berlin, New Jersey, United States

114-Northwestern University

🇺🇸

Chicago, Illinois, United States

582-SI Institute of Neurology,Psychiatry&Narcology of NAMSU

🇺🇦

Kharkiv, Ukraine

510-CI of Kyiv RC Regional Psychiatric-Narcological Medical Association, Depart #10 (male), Dept #2 (female)

🇺🇦

Hlevakha, Ukraine

164-Artemis Institute for Clinical Research

🇺🇸

San Diego, California, United States

124-Altea Research Institute

🇺🇸

Las Vegas, Nevada, United States

165-CITrials

🇺🇸

Santa Ana, California, United States

101-American Medical Research

🇺🇸

Chicago, Illinois, United States

170-Suburban Research Associates

🇺🇸

Downingtown, Pennsylvania, United States

168-Atlanta Center for Medical Research

🇺🇸

Atlanta, Georgia, United States

622-Instituto Medico Damic Srl

🇦🇷

Córdoba, Argentina

137-Innovative Clinical Research, Inc.

🇺🇸

Lauderhill, Florida, United States

146-Premier Clinical Research Institute, Inc.

🇺🇸

Miami, Florida, United States

156-Woodland International Research Group, LLC

🇺🇸

Little Rock, Arkansas, United States

105-ProScience Research Group

🇺🇸

Culver City, California, United States

593-Specialized Hospital for Neuropsychiatric Diseases "Sveti Vracevi"

🇷🇸

Novi Kneževac, Serbia

517-Zirmunai Mental Health Center, Public Institution

🇱🇹

Vilnius, Lithuania

424-Institute of Mental health

🇷🇸

Belgrad, Serbia

518-Kaunas City Outpatient Clinic, Public Institution

🇱🇹

Kaunas, Lithuania

484-Medical Center Puriena JSC

🇱🇹

Silute, Lithuania

425-Clinical Hospital Center "Dr. Dragisa Misovic-Dedinje", Clinic of Psychiatry

🇷🇸

Belgrade, Serbia

471-Clinic for Psychiatric Diseases "Dr Laza Lazarevic"

🇷🇸

Belgrade, Serbia

493-Special Neuropsychiatric Hospital Kovin

🇷🇸

Kovin, Serbia

429-Clinical Center Kragujevac, Clinic of Psychiatry

🇷🇸

Kragujevac, Serbia

587-Institute of Mental Health

🇷🇸

Belgrad, Serbia

483-Romuvos klinika, UAB

🇱🇹

Kaunas, Lithuania

423-Clinical Center Kragujevac

🇷🇸

Kragujevac, Serbia

430-Psychiatric Clinic, Clinical Center Kragujevac

🇷🇸

Kragujevac, Serbia

171-Alea Research Institute

🇺🇸

Phoenix, Arizona, United States

145-Carolina Behavioral Care

🇺🇸

Durham, North Carolina, United States

115-Psychiatric and Behavioral Solutions LLC

🇺🇸

Salt Lake City, Utah, United States

356-Chatham-Kent Clinical Trials Research Ctr

🇨🇦

Chatham, Canada

459-Federal State Budgetary Research Institution "Mental Health Science Center"

🇷🇺

Moscow, Russian Federation

496-SPHI "City Mental Hospital #3 n.a. I.I Skvortsov-Stepanov

🇷🇺

Saint Petersburg, Russian Federation

403-University Multiprofile hospital for activated treatment Sveti Georgi, Clinic of psychiatry

🇧🇬

Plovdiv, Bulgaria

106-New Hope Clinical Research

🇺🇸

Charlotte, North Carolina, United States

123-Synergy San Diego

🇺🇸

Lemon Grove, California, United States

570-Medical Centre "Sveti Naum"

🇧🇬

Sofia, Bulgaria

592-Medical center Spectar - Plovdiv EOOD

🇧🇬

Plovdiv, Bulgaria

111-Woodland Research Northwest, LLC

🇺🇸

Rogers, Arkansas, United States

167-CITrials - Bellflower

🇺🇸

Bellflower, California, United States

108-Collaborative Nueroscience Network, LLC

🇺🇸

Torrance, California, United States

125-Galiz Research

🇺🇸

Hialeah, Florida, United States

162-Synexus Clinical Research, Inc.

🇺🇸

Atlanta, Georgia, United States

102-Northwest Behavioral Research Center

🇺🇸

Marietta, Georgia, United States

130-Alexian Brothers Center for Psychiatric Research

🇺🇸

Hoffman Estates, Illinois, United States

118-Lake Charles Clinical Trials

🇺🇸

Lake Charles, Louisiana, United States

153-Albuquerque Neuroscience Inc.

🇺🇸

Albuquerque, New Mexico, United States

140-Synexus Clinical Research, Inc - 140

🇺🇸

Jamaica, New York, United States

104-Neurobehavioral Research, Inc.

🇺🇸

Cedarhurst, New York, United States

110-Cutting Edge Research Group

🇺🇸

Oklahoma City, Oklahoma, United States

128-Finger Lakes Clinical Research

🇺🇸

Rochester, New York, United States

103-Pillar Clinical Research, LLC

🇺🇸

Richardson, Texas, United States

127-University Hills Clinical Research

🇺🇸

Irving, Texas, United States

610-Clinica Privada Banfield S.A.

🇦🇷

Buenos Aires, Argentina

603-Fundación para el Estudio y Tratamiento de las Enfermedades Mentales - FETEM

🇦🇷

Ciudad Autonoma Buenos Aires, Argentina

625-NOVAIN Neurociencias Group

🇦🇷

Ciudad Autonoma de Buenos Aires, Argentina

601-CENydET- Centro Neurobiologico y de Estres Traumatico-Biopsychomedical Research Group SRL

🇦🇷

Ciudad Autonoma de Buenos Aire, Argentina

498-DCC "Mladost M" - Varna, OOD

🇧🇬

Varna, Bulgaria

602-FunDamoS

🇦🇷

Ciudad Autonoma de Buenos Aire, Argentina

626-Sanatorio Prof. Leon S. Morra S.A.

🇦🇷

Cordoba, Argentina

607-Resolution Psicopharmacology Research Institute

🇦🇷

Ciudad de Mendoza, Argentina

624-Centro Especializado en Neurociencias CEN

🇦🇷

Córdoba, Argentina

617-INSA Instituto de Neurociencias San Agustin S.A.

🇦🇷

La Plata, Argentina

454-Mental Health Centre 'Prof. Dr. Ivan Temkov', EOOD

🇧🇬

Burgas, Bulgaria

623-Clinica Privada de Salud Mental Santa Teresa de Avila

🇦🇷

La Plata, Argentina

533-State Psychiatric Hospital - Kardzhali, EOOD

🇧🇬

Kardzhali, Bulgaria

532-MHAT "Dr. Hristo Stambolski", EOOD

🇧🇬

Kazanlak, Bulgaria

569-State Psychiatric Hospital - Lovech

🇧🇬

Lovech, Bulgaria

406-State Psychiatric Hospital - Pazardzhik AD

🇧🇬

Pazardzhik, Bulgaria

535-UMHAT 'Dr. Georgi Stranski', EAD

🇧🇬

Pleven, Bulgaria

563-MC-Hipokrat-N E00D

🇧🇬

Plovdiv, Bulgaria

497-MHC - Sofia, EOOD

🇧🇬

Sofia, Bulgaria

526-DCC "Sv. Vrach and Sv. Sv. Kuzma and Damyan", OOD

🇧🇬

Sofia, Bulgaria

402-Military Medical Academy, Multiprofile Hospital for Actie Treatment - Sofia

🇧🇬

Sofia, Bulgaria

405-UMHAT "Alexandrovska" EAD

🇧🇬

Sofia, Bulgaria

586-Medical Center Mentalcare OOD

🇧🇬

Plovdiv, Bulgaria

568-Medical Center Hera EOOD

🇧🇬

Sofia, Bulgaria

528-Medical Center Intermedica, OOD

🇧🇬

Sofia, Bulgaria

590-State Psychiatric Hospital - Tzarev Brod

🇧🇬

Tsarev Brod, Bulgaria

404-MHAT-Targovishte, AD

🇧🇬

Targovishte, Bulgaria

455-Mental Health Center - Veliko Tarnovo EOOD

🇧🇬

Veliko Tarnovo, Bulgaria

401-Mental Health Center-Vratsa EOOD

🇧🇬

Vratsa, Bulgaria

Chatham-Kent Clinical Trials Research Ctr

🇨🇦

Chatham, Ontario, Canada

351-McGill University Health Ctr Allan Memorial Int.

🇨🇦

Montréal, Quebec, Canada

550-Clinic for psychiatry Vrapce

🇭🇷

Zagreb, Croatia

557 - Clinic for psychiatry Vrapce

🇭🇷

Zagreb, Croatia

519-A-SHINE s.r.o.

🇨🇿

Plzen, Czechia

594-Klinika za psihijatriju Sveti Ivan, n/p Igor Filipčić or Marija Zelenika

🇭🇷

Zagreb, Croatia

583-Narodni ustav dusevniho zdravi

🇨🇿

Klecany, Czechia

512-NeuropsychiatrieHK s.r.o.

🇨🇿

Hradec Králové, Czechia

511-Psychiatrie Ricany s.r.o.

🇨🇿

Říčany, Czechia

513-CLINTRIAL s.r.o.

🇨🇿

Praha 10, Czechia

525-Podlaskie Centrum Psychogeriatrii

🇵🇱

Białystok, Poland

499-MUDr. Tibor Miklos

🇨🇿

Praha 10, Czechia

410-Dr. Máthé és Társa Bt.

🇭🇺

Kalocsa, Bács-Kiskun Megye, Hungary

456-Semmelweis University Department of Psychiatry and Psychotherapy

🇭🇺

Budapest, Pest Megye, Hungary

520-Nyiro Gyula Korhaz - Orszagos Pszichiatriai es Addiktologiai Intezet

🇭🇺

Budapest, Hungary

411-ÓBudai Egészségűgyi Centrum Kft

🇭🇺

Budapest, Pest Megye, Hungary

440-PsychoTech Kft.

🇭🇺

Pécs, Hungary

566-Ospedale San Raffaele (San Raffaele Turro)

🇮🇹

Milano, Italy

553-AO Città della Salute e della Scienza di Torino

🇮🇹

Torino, Italy

579-Centrum Badan Klinicznych P.I. House Sp. z o.o.

🇵🇱

Gdańsk, Poland

502-Przychodnia Srodmiescie Sp. z o. o.

🇵🇱

Bydgoszcz, Poland

501-Specjalistyczna Praktyka Lekarska Marek Domański

🇵🇱

Lublin, Poland

578-MSCZ im. Prof. J. Mazurkiewicza

🇵🇱

Pruszków, Poland

417-State Budget Healthcare Institution of Stavropol Region (Regional Specialized Psychiatric Hospital #2)

🇷🇺

Tonnel'nyy, Stavropol Region, Russian Federation

505-GUZ Lipetsk Regional psychoneurological Hospital #1

🇷🇺

Plekhanovo, Lipetsk Region, Russian Federation

573-SBIH of Moscow "Psychiatric Clinical Hospital # 4 n.a. P.B. Gannushkin" Short name: PCH N4 n.a. P.B.Gannushkin

🇷🇺

Moscow, Russian Federation

418-State Budget Healthcare Institution of Arkhangelsk Region "Arkhangelsk Clinical Psychiatric Hospital"

🇷🇺

Arkhangel'sk, Russian Federation

419-State municipal healthcare Institution "Leningrad region psychoneurological center"

🇷🇺

Leningrad, Russian Federation

581-SBIH of Moscow "Psych Clinical Hospital #1 N.A. Alekseev"

🇷🇺

Moscow, Russian Federation

451-V. M. Bekhterev National Research Medical Center For Psychiatry and Neurology

🇷🇺

Saint Petersburg, Russian Federation

415-Saint-Petersburg State Healthcare Institution "Saint Nicolas Wonderworker Psychiatric Hospital"

🇷🇺

Saint Petersburg, Russian Federation

453-"Saint-Petersburg Scientific Research Psychoneurological Institute n.a. V.M. Bekhterev"

🇷🇺

Saint Petersburg, Russian Federation

465-"Saint-Petersburg Scientific Research Psychoneurological Institute N.A. V.M. Bekhterev"

🇷🇺

Saint Petersburg, Russian Federation

495-FSBI "National Medical Scientifi Center of Psychiatry and Neurology n.a. V.M. Bekhterev" MoH

🇷🇺

Saint Petersburg, Russian Federation

443-Saint-Petersburg State Budget Healthcare Institution "Psychoneurological Center #5"

🇷🇺

Saint Petersburg, Russian Federation

444-SPHI "City Mental Hospital #3 n.a. I.I Skvortsov-Stepanov"

🇷🇺

Saint Petersburg, Russian Federation

452-Saint Petersburg State Public Institution of Healthcare "City Psychiatric Hospital #3 n.a.I.I. Skvortsov-Stepanov

🇷🇺

Saint Petersburg, Russian Federation

458-State Budget Healthcare Institution "Samara Psychiatric Hospital"

🇷🇺

Saint Petersburg, Russian Federation

571-St. Petersburg SHI "Psychoneurological Dispensary #10"

🇷🇺

Saint-Petersburg, Russian Federation

416-FSBEI HE "Smolensk State Medical University" of the MoH of the RF

🇷🇺

Smolensk, Russian Federation

428-Clinical center of Serbia

🇷🇸

Belgrade, Serbia

464-Saint Petersburg State Budget Healthcare Institution "City Psychiatric Hospital No. 6 (Inpatient Department with Treatment Center)"

🇷🇺

Saint-Petersburg, Russian Federation

420-"Podderzhka" Research and Educational Center of Psychotherapy Limited Liability Company

🇷🇺

Stavropol', Russian Federation

572-Klinika StoLet" Ltd.

🇷🇺

Tomsk, Russian Federation

466-OOO "Lion-Med"

🇷🇺

Voronezh, Russian Federation

422-State Budget Healthcare Institution of Yaroslavl Region "Yaroslavl Region Clinical Psychiatric Hospital"

🇷🇺

Yaroslavl, Russian Federation

524-General Hospital Euromedik

🇷🇸

Belgrade, Serbia

584-Clinic for Psychiatry, Clinical Canter of Serbia

🇷🇸

Belgrad, Serbia

472-Special Hospital for Psychiatric Diseases "Kovin"

🇷🇸

Kovin, Serbia

427-Clinical Center Nis, Clinic of Mental Health

🇷🇸

Nis, Serbia

585-Special Hospital for Psychiatric Diseases "Gornja Toponica"

🇷🇸

Niš, Serbia

574-Hospital Clinic de Barcelona

🇪🇸

Barcelona, Spain

476-FIDMAG Germanes Hospitalaries

🇪🇸

Barcelona, Spain

588-Institucion Hospitalaria Hestia Palau - Ensayos clinicos

🇪🇸

Barcelona, Spain

475-Hospital Gregorio Marañon

🇪🇸

Madrid, Spain

575-Hospital Universitario 12 de Octubre

🇪🇸

Madrid, Spain

431-Centro de Salud Parquesol, 2ª planta - Servicio de Psiquiatria

🇪🇸

Valladolid, Spain

494-CSM La Corredoria

🇪🇸

Oviedo, Spain

438-Communal Establishment "Odesa Regional Psychiatric Hospital #2"

🇺🇦

Odessa, Oblast, Ukraine

529-Hospital Provincial de Zamora

🇪🇸

Zamora, Spain

462-Communal Establishment "I.I. Mechnykov Dnipropetrovsk Regional Clinical Hospital"

🇺🇦

Dnipro, Ukraine

434-State Institution "Institute of Neurology, Psychiatry and Narcology of NAMS of Ukraine", Department of Urgent Psychiatry and Narcology

🇺🇦

Kharkiv, Ukraine

461-Kherson Regional Psychiatric Hospital

🇺🇦

Kherson, Ukraine

507-Main Military Clinical Hospital of MDU

🇺🇦

Kyiv, Ukraine

447-Ukrainian Scientific Research Institute of Social and Forensic Psychiatry and Narcology of Ministry of Healthcare of Ukraine

🇺🇦

Kyiv, Ukraine

Kyiv Regional Medical Incorporation Psychiatry Center of Novel Treatment and Rehabilitation of Psychotic Disorders, Department #29, Department #30

🇺🇦

Kyiv, Ukraine

564-Regional Clinical Psychiatric Hospital

🇺🇦

Nove, Ukraine

460-Kyiv City Psychoneurological Hospital #3, General Psychiatry Department No. 2

🇺🇦

Kyiv, Ukraine

509-CI Odesa Regional Medical Centre of Mental Health

🇺🇦

Odesa, Ukraine

Communal Establishment "Acad. O.I. Iushchenko Vinnytsia Regional Psychoneurologic Hospital"

🇺🇦

Vinnytsia, Ukraine

432-Municipal Institution "Vinnytsya Regional Psychoneurological Hospital n.a. Acad. O.I. Yushchenko", Male Department No 14, Female Department No 15, Vinnytsya National Medical University n.a. M.I. Pyrogov, Dept of Psychiatry, Narcology and Psychothera

🇺🇦

Vinnytsia, Ukraine

508-CI Cherkasy Regional Psychiatric Hospital of ChRC Female Dept #11, Male Dept #12

🇺🇦

Smila, Ukraine

591-Municipal non-profit enterprise "Transcarpathian Regional Medical Center of Mental Health and Medicine of Addictions" of the Transcarpathian Regional Council, Department of psychiatry

🇺🇦

Úzhgorod, Ukraine

537 - Clinic for psychiatry Vrapce

🇭🇷

Zagreb, Croatia

536 - Clinic for psychiatry Vrapce

🇭🇷

Zagreb, Croatia

433-SI "Institute of Neurology, Psychiatry and Narcology of National Academy of Medical Sciences of Ukraine"

🇺🇦

Kharkiv, Ukraine

435-Kyiv Regional Medical Incorporation "Psychiatry". Center of Novel Treatment and Rehabilitation of Psychotic disorders, build 5, Department #30

🇺🇦

Kyiv, Ukraine

567-CIH Kharkiv Regional Clinical Psychiatric Hospital #3 Psychiatric Department of Primary Psychotic Episod Short Site name: CIH KRCPH #3 PD of PPE

🇺🇦

Kharkiv, Ukraine

© Copyright 2025. All Rights Reserved by MedPath